Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2003
03/27/2003WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
03/27/2003WO2003024529A1 Simplified sarcodictyn derivatives as anti-tumor agents
03/27/2003WO2003024451A1 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024441A1 Novel use of tricyclic compound
03/27/2003WO2003024397A2 Enhancement of learning and memory and treatment of amnesia
03/27/2003WO2003024220A1 Delta 1-pyrrolines used as pesticides
03/27/2003WO2003002715A3 Compositions and methods for labeling oligonucleotides
03/27/2003WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
03/27/2003WO2002078628A3 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
03/27/2003WO2002060879A3 Bacterial gyrase inhibitors and uses thereof
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002026220A3 Taxoid conjugates as antimitotic and antitumor agents
03/27/2003US20030060638 C7 carbamate substituted taxanes
03/27/2003US20030060629 Pyrazine derivatives as modulators of tyrosine kinases
03/27/2003US20030060626 Fungicides
03/27/2003US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain
03/27/2003US20030060494 Dipeptidyl peptidase IV inhibiting agent; treatment of gastrointestinal disorders
03/27/2003US20030060485 (+)-norcisapride
03/27/2003US20030060476 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060473 Piperazine compounds as inhibitors of MMP or TNF
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030059785 Detection of markers in nascent proteins
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2461074A1 Methods and compositions of novel triazine compounds
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003CA2460578A1 Propanolamine derivative having 1,4-benzodioxane ring
03/27/2003CA2460244A1 Simplified sarcodictyn derivatives as anti-tumor agents
03/27/2003CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
03/26/2003EP1295879A1 Medicinal compositions containing propenone derivatives
03/26/2003EP1295878A1 Novel pyrazinone derivatives
03/26/2003EP1295876A1 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/26/2003EP1295875A1 Heterocyclic compounds
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294715A1 Quinazoline ditosylate salt compounds
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1212311B1 Chalcone coumarins
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1140917B1 S-oxide lipid lowering compounds
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
03/26/2003EP1021432B1 Halogen substituted tetracyclic tetrahydrofuran derivatives
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0841926B1 Endothelin receptor antagonists
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
03/26/2003CN1405162A C7 ester-substituted taxane
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103763C Process for preparation of substituted pyrimidines
03/26/2003CN1103760C 1,3-dihydro-2H-imidazol-2-one derivatives having PDEIV and cytokinin inhibiting activity
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538105 Catalysts for the enantioselective epoxidation of C═C double bonds
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6538001 Crystalline modification of 5-fluoro-1-(tetrahydro-2-furyl) uracil and complex compounds based thereon, producing antineoplastic effect
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2071717C Antipsychotic benzodioxan derivatives
03/20/2003WO2003022840A1 Pyridine derivatives as raf kinase inhibitors
03/20/2003WO2003022839A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003WO2003022838A1 Pyridine substituted furan derivatives as raf kinase inhibitors
03/20/2003WO2003022837A1 Heterocycle-carboxamide derivatives as raf kinase inhibitors
03/20/2003WO2003022836A1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022833A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022832A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003004466A3 Dye-sulfenates for dual phototherapy
03/20/2003WO2003004457A3 Preparation process for atorvastatin and intermediates
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002100836A8 Compounds, compositions and methods for modulating beta-amyloid production
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003US20030055266 Small molecule modulators of G protein-coupled receptors
03/20/2003US20030055259 Method for producing 5-aryl nicotinaldehydes
03/20/2003US20030055256 Alkoxy impurity is reacted with an ether cleaving agent to generate the corresponding phenol, which is separated, yielding the desired product substantially free of alkoxy impurities
03/20/2003US20030055251 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
03/20/2003US20030055243 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055087 As analgesic
1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 694